#01 Defence
Chief of Defence Forces Praises Troops' Valour and Sacrifice Along Western Frontiers
Field Marshal Syed Asim Munir celebrates Eidul Azha with frontline troops, commending their courage and sacrifices in defending Pakistan against terrorism and hostile threats.
#02 Pakistan
PTI Accuses Gilgit-Baltistan Government of Detaining Party Leaders During Election Campaign
Pakistan Tehreek-e-Insaf (PTI) alleges that its leaders, including Khyber Pakhtunkhwa president Junaid Akbar, were detained by the Gilgit-Baltistan administration during election
#03 Business
Achakzai Urges Reopening of Chaman Border Crossing
Opposition leader Mahmood Khan Achakzai calls for the reopening of the Chaman border, highlighting its importance to local livelihoods and economic activity.
#04 Crime
LHC Bars Arbitrary Passenger Offloading by FIA
Lahore High Court issues guidelines restricting Federal Investigation Agency from offloading passengers without valid legal grounds, emphasizing transparency and documentation.
Defence
Pakistan Government Slashes Fuel Prices by Rs22 Per Litre for Eidul Azha
Fuel prices in Pakistan have been reduced by Rs22 per litre, with petrol and high-speed diesel now costing Rs381.78 and Rs380.
Defence
Trump's Iran Deal Tease Puts World on Edge
US President Donald Trump announced he would decide soon on a proposed deal to extend a ceasefire with Iran, amid ongoing disagreements over key issues like nuclear weapons and
Defence
Dar Quashes Rumours of Pakistan Joining Abraham Accords
Pakistani Foreign Minister Ishaq Dar clarifies his country's stance on the Abraham Accords, emphasizing its commitment to a Palestinian state.
Pakistan
President Asif Ali Zardari Honors Father’s Memory with Fateha and Flowers at Baloo Ja Quba
Pakistani President Asif Ali Zardari paid tribute to his father, Sardar Hakim Ali Zardari, by offering Fateha and laying flowers during a poignant visit to Baloo Ja Quba.
Health
Teclistamab Extends Remission in Relapsed Myeloma with 70% Progression-Free Survival at 18 Months
A major Phase III clinical trial shows teclistamab significantly extends remission and survival for patients with relapsed multiple myeloma, outperforming standard therapies.